REVA Medical, Inc. (RVA) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 147 transactions totaling $58.4M, demonstrating a bearish sentiment with -$57.7M in net insider flow. The most recent transaction on Nov 11, 2019 involved a sale of 85,186 shares valued at $0.
No significant insider buying has been recorded for RVA in the recent period.
No significant insider selling has been recorded for RVA in the recent period.
Based on recent SEC filings, insider sentiment for RVA is bearish with an Insider Alignment Score of 1/100 and a net flow of -$57.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at REVA Medical, Inc. (RVA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading RVA stock, having executed 147 transactions in the past 90 days. The most active insider is Capital Everest Lp Saints (Executive), who has made 10 transactions totaling $35.2M.
Get notified when executives and directors at RVA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 11, 2019 | H. Dovey Brian | Executive | Sale | 85,186 | $N/A | $0 | |
| Nov 11, 2019 | H. Dovey Brian | Executive | Sale | 3,606,002 | $N/A | $0 | |
| Nov 11, 2019 | H. Dovey Brian | Executive | Sale | 15,500 | $N/A | $0 | |
| Nov 11, 2019 | H. Dovey Brian | Executive | Sale | 15,500 | $N/A | $0 | |
| Jun 29, 2018 | H. Dovey Brian | Executive | Other | 3,000 | $N/A | $0 | |
| Jun 29, 2018 | H. Dovey Brian | Executive | Other | 3,000 | $N/A | $0 | |
| Jul 25, 2017 | H. Dovey Brian | Executive | Other | 5,000 | $N/A | $0 | |
| Jul 25, 2017 | H. Dovey Brian | Executive | Other | 5,000 | $N/A | $0 | |
| Jul 9, 2017 | H. Dovey Brian | Executive | Award | 6,000 | $N/A | $0 | |
| Aug 1, 2016 | H. Dovey Brian | Executive | Other | 7,500 | $N/A | $0 | |
| Aug 1, 2016 | H. Dovey Brian | Executive | Other | 7,500 | $N/A | $0 | |
| May 25, 2016 | H. Dovey Brian | Executive | Award | 10,000 | $N/A | $0 | |
| May 27, 2015 | H. Dovey Brian | Executive | Award | 15,000 | $N/A | $0 | |
| Mar 23, 2012 | Associates Lp Dp V. | Executive | Sale | 39,136 | $5.16 | $201.9K | |
| Mar 23, 2012 | V. Lp Domain Partners | Executive | Sale | 1,656,581 | $5.16 | $8.5M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 16 | $58.0M | 48.5% |
Exercise (Options)(X) | 32 | $35.2M | 29.5% |
Conversion(C) | 72 | $21.7M | 18.1% |
Other(J) | 16 | $4.1M | 3.5% |
Purchase(P) | 5 | $341.3K | 0.3% |
Payment(F) | 2 | $133.8K | 0.1% |
Exercise(M) | 1 | $610 | 0.0% |
Award(A) | 3 | $0 | 0.0% |
Insider selling pressure at REVA Medical, Inc. has increased, with 13 insiders executing 147 transactions across all time. Total sales of $58.0M significantly outpace purchases of $341.3K, resulting in a net outflow of $57.7M. This selling activity appears largely discretionary, which may warrant closer attention from investors.